Expanding natural chemical space may improve AI drug discovery by providing biologically relevant data to generate more clinically impactful therapeutics, says Guillaume Vandenesch, CEO and co-founder of Generare, in this exclusive interview.
Guillaume Vandenesch
Advertisement
Guillaume Vandenesch is CEO and co-founder of Generare.
Articles by Guillaume Vandenesch
Advertisement
Latest Updated Articles
Advertisement
Advertisement